These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 30950680)

  • 21. Comparative penetration of moxifloxacin and gatifloxacin in rabbit aqueous humor after topical dosing.
    Levine JM; Noecker RJ; Lane LC; Herrygers L; Nix D; Snyder RW
    J Cataract Refract Surg; 2004 Oct; 30(10):2177-82. PubMed ID: 15474833
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Endophthalmitis after uncomplicated cataract surgery with the use of fourth-generation fluoroquinolones: a retrospective observational case series.
    Moshirfar M; Feiz V; Vitale AT; Wegelin JA; Basavanthappa S; Wolsey DH
    Ophthalmology; 2007 Apr; 114(4):686-91. PubMed ID: 17184840
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Aqueous penetration of orally and topically administered moxifloxacin.
    Sharma T; Kamath MM; Kamath MG; Nayak RR; Bairy KL; Musmade PB
    Br J Ophthalmol; 2015 Sep; 99(9):1182-5. PubMed ID: 25824259
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Ocular pharmacokinetics/pharmacodynamics of besifloxacin, moxifloxacin, and gatifloxacin following topical administration to pigmented rabbits.
    Proksch JW; Ward KW
    J Ocul Pharmacol Ther; 2010 Oct; 26(5):449-58. PubMed ID: 20874668
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparison of corneal and aqueous humor penetration of moxifloxacin, gatifloxacin and levofloxacin during keratoplasty.
    Fukuda M; Yamada M; Kinoshita S; Inatomi T; Ohashi Y; Uno T; Shimazaki J; Satake Y; Maeda N; Hori Y; Nishida K; Kubota A; Nakazawa T; Shimomura Y
    Adv Ther; 2012 Apr; 29(4):339-49. PubMed ID: 22529026
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A comparison of the fourth-generation fluoroquinolones gatifloxacin 0.3% and moxifloxacin 0.5% in terms of ocular tolerability.
    Donnenfeld E; Perry HD; Chruscicki DA; Bitterman A; Cohn S; Solomon R
    Curr Med Res Opin; 2004 Nov; 20(11):1753-8. PubMed ID: 15537475
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of gatifloxacin 0.3% and moxifloxacin 0.5% ophthalmic solutions on human corneal epithelium following 2 dosing regimens.
    Price MO; Price FW; Maclellan D
    J Cataract Refract Surg; 2005 Nov; 31(11):2137-41. PubMed ID: 16412928
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Penetration pharmacokinetics of topically administered 0.5% moxifloxacin ophthalmic solution in human aqueous and vitreous.
    Hariprasad SM; Blinder KJ; Shah GK; Apte RS; Rosenblatt B; Holekamp NM; Thomas MA; Mieler WF; Chi J; Prince RA
    Arch Ophthalmol; 2005 Jan; 123(1):39-44. PubMed ID: 15642810
    [TBL] [Abstract][Full Text] [Related]  

  • 29. In vitro antibiotic susceptibility of preoperative normal conjunctival bacteria.
    Ta CN; He L; Mino de Kaspar H
    Eye (Lond); 2009 Mar; 23(3):559-60. PubMed ID: 18356928
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Ocular penetration and pharmacokinetics of topical gatifloxacin 0.3% and moxifloxacin 0.5% ophthalmic solutions after keratoplasty.
    Holland EJ; Lane SS; Kim T; Raizman M; Dunn S
    Cornea; 2008 Apr; 27(3):314-9. PubMed ID: 18362660
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Antibacterial activity of the fourth-generation fluoroquinolones gatifloxacin and moxifloxacin against ocular pathogens.
    Callegan MC; Ramirez R; Kane ST; Cochran DC; Jensen H
    Adv Ther; 2003; 20(5):246-52. PubMed ID: 14964344
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Postantibiotic effects and bactericidal activities of levofloxacin and gatifloxacin at concentrations simulating those of topical ophthalmic administration against fluoroquinolone-resistant and fluoroquinolone-sensitive methicillin-resistant Staphylococcus aureus strains.
    Hoshi S; Kikuchi K; Sasaki T; Sotozono C; Kinoshita S; Hiramatsu K
    Antimicrob Agents Chemother; 2008 Aug; 52(8):2970-3. PubMed ID: 18490505
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The effect of cataract surgery on ocular levels of topical moxifloxacin.
    Mather R; Stewart JM; Prabriputaloong T; Wong J; McLeod SD
    Am J Ophthalmol; 2004 Oct; 138(4):554-9. PubMed ID: 15488780
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of gatifloxacin ophthalmic solution 0.3% on human corneal endothelial cell density and aqueous humor gatifloxacin concentration.
    Price MO; Quillin C; Price FW
    Curr Eye Res; 2005 Jul; 30(7):563-7. PubMed ID: 16020290
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparison of the effects of fourth-generation fluoroquinolones on corneal re-epithelialization in rabbit eyes.
    Moshirfar M; Chew J; Werner L; Meyer JJ; Hunter B; Stevens S; Jensen M; Kleinmann G; Mamalis N
    Graefes Arch Clin Exp Ophthalmol; 2008 Oct; 246(10):1455-61. PubMed ID: 18642018
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The impact of short-term topical gatifloxacin and moxifloxacin on bacterial injection after hypodermic needle passage through human conjunctiva.
    Pettey JH; Mifflin MD; Kamae K; McEntire MW; Pettey DH; Callegan MC; Brown H; Olson RJ
    J Ocul Pharmacol Ther; 2013 Jun; 29(5):450-5. PubMed ID: 23425429
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Calculation of AQCmax: comparison of five ophthalmic fluoroquinolone solutions*.
    Fukuda M; Sasaki H
    Curr Med Res Opin; 2008 Dec; 24(12):3479-86. PubMed ID: 19032129
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prevention of Staphylococcus aureus endophthalmitis with topical gatifloxacin in a rabbit prophylaxis model.
    de Castro LE; Sandoval HP; Bartholomew LR; Vroman DT; Solomon KD
    J Ocul Pharmacol Ther; 2006 Apr; 22(2):132-8. PubMed ID: 16722799
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prophylactic efficacy of ophthalmic quinolones in experimental endophthalmitis in rabbits.
    Wada T; Kozai S; Tajika T; Sakaki H; Suzuki T; Ohashi Y
    J Ocul Pharmacol Ther; 2008 Jun; 24(3):278-89. PubMed ID: 18462067
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Intraocular penetration of sequentially instilled topical moxifloxacin, gatifloxacin, and levofloxacin.
    Sugioka K; Fukuda M; Komoto S; Itahashi M; Yamada M; Shimomura Y
    Clin Ophthalmol; 2009; 3():553-7. PubMed ID: 19898627
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.